What Are Wall Street Analysts' Target Price for Henry Schein Stock?
Henry Schein has outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.
Yahoo15 gün önceHSIC
Palo Alto To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Wednesday
Analysts changed outlook on top names. Piper Sandler raises Mercury Systems' target price, Ascendiant Capital boosts Alzamend Neuro's target price, BTIG raises Henry Schein's target price, Cantor Fitzgerald increases Palo Alto's target price, Morgan Stanley cuts Baidu's target price, Cantor Fitzgerald slashes Crowdstrike Holdings' target price, Baird raises Donaldson Company's target price, B of A Securities cuts Pony AI's target price.
Benzinga16 gün önceHSIC
BTIG Maintains Buy on Henry Schein, Raises Price Target to $110
BTIG analyst David Larsen maintains Henry Schein (NASDAQ:HSIC) with a Buy and raises the price target from $100 to $110.
Benzinga16 gün önceHSIC
HSIC Raises 2026 Outlook as Sales and Margin Momentum Accelerates
Henry Schein's stronger Q2 sales and margins prompt a 2026 outlook hike, but second-half savings execution remains key to sustaining earnings momentum.
Yahoo17 gün önceHSIC
3 Unpopular Stocks with Open Questions
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.
Yahoo17 gün önceHSIC
How the U.K. VAT Ruling Could Reshape Align's 2026 Earnings Outlook
Align's $37.5M U.K. VAT liability, new 20% VAT charges and pending appeal add fresh earnings uncertainty amid currency and mix pressures.
Yahoo18 gün önceHSIC
5 Insightful Analyst Questions From Henry Schein’s Q2 Earnings Call
Henry Schein delivered a positive second quarter, with results exceeding Wall Street’s expectations and earning a strong market response. Management attributed the outperformance to accelerating internal sales growth, robust gains in its global dental merchandise segment, and early benefits from value creation initiatives. CEO Frederick Lowery emphasized the company’s success in converting occasional buyers into engaged customers and highlighted strong market share gains, particularly in the U.S
Yahoo22 gün önceHSIC
Henry Schein (HSIC) Q2 2026 Earnings Call Transcript
Cloud-based dental software drives margin expansion and record customer growth.
Yahoo24 gün önceHSIC
Should Value Investors Buy Henry Schein (HSIC) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Yahoo25 gün önceHSIC
HSIC or SAUHY: Which Is the Better Value Stock Right Now?
HSIC vs. SAUHY: Which Stock Is the Better Value Option?
Yahoo29 gün önceHSIC
Barclays Maintains Overweight on Henry Schein, Raises Price Target to $100
Barclays analyst Glen Santangelo maintains Henry Schein (NASDAQ:HSIC) with a Overweight and raises the price target from $86 to $100.
Benzinga29 gün önceHSIC
Should Henry Schein’s Raised 2026 Sales Growth Guidance Require Action From Henry Schein (HSIC) Investors?
Henry Schein, Inc. reported past Q2 2026 results with sales rising to US$3,458 million and net income to US$94 million, alongside higher basic and diluted earnings per share from continuing operations versus a year earlier. Importantly for long-term watchers, management also raised its 2026 total sales growth guidance, signaling greater confidence in the company’s operating initiatives and demand trends. Now we’ll examine how Henry Schein’s raised 2026 sales outlook reshapes its existing...
Yahoo29 gün önceHSIC
UBS Maintains Neutral on Henry Schein, Raises Price Target to $94
UBS analyst Kevin Caliendo maintains Henry Schein (NASDAQ:HSIC) with a Neutral and raises the price target from $89 to $94.
Benzingageçen ayHSIC
Citigroup Maintains Buy on Henry Schein, Raises Price Target to $112
Citigroup analyst Daniel Grosslight maintains Henry Schein (NASDAQ:HSIC) with a Buy and raises the price target from $100 to $112.
Benzingageçen ayHSIC